These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 24982867)

  • 1. Docking applied to the prediction of the affinity of compounds to P-glycoprotein.
    Palestro PH; Gavernet L; Estiu GL; Bruno Blanch LE
    Biomed Res Int; 2014; 2014():358425. PubMed ID: 24982867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting binding to p-glycoprotein by flexible receptor docking.
    Dolghih E; Bryant C; Renslo AR; Jacobson MP
    PLoS Comput Biol; 2011 Jun; 7(6):e1002083. PubMed ID: 21731480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Homology Modeling of the Human P-glycoprotein (ABCB1) and Insights into Ligand Binding through Molecular Docking Studies.
    Mora Lagares L; Minovski N; Caballero Alfonso AY; Benfenati E; Wellens S; Culot M; Gosselet F; Novič M
    Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32517082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In silico model for P-glycoprotein substrate prediction: insights from molecular dynamics and in vitro studies.
    Prajapati R; Singh U; Patil A; Khomane KS; Bagul P; Bansal AK; Sangamwar AT
    J Comput Aided Mol Des; 2013 Apr; 27(4):347-63. PubMed ID: 23612916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting P-glycoprotein-mediated drug transport based on support vector machine and three-dimensional crystal structure of P-glycoprotein.
    Bikadi Z; Hazai I; Malik D; Jemnitz K; Veres Z; Hari P; Ni Z; Loo TW; Clarke DM; Hazai E; Mao Q
    PLoS One; 2011; 6(10):e25815. PubMed ID: 21991360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In Silico Prediction of P-glycoprotein Binding: Insights from Molecular Docking Studies.
    Vilar S; Sobarzo-Sánchez E; Uriarte E
    Curr Med Chem; 2019; 26(10):1746-1760. PubMed ID: 29189117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In silico study of desmosdumotin as an anticancer agent: homology modeling, docking and molecular dynamics simulation approach.
    Gadhe CG; Kothandan G; Cho SJ
    Anticancer Agents Med Chem; 2013 Dec; 13(10):1636-44. PubMed ID: 23796247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Searching for New Leads To Treat Epilepsy: Target-Based Virtual Screening for the Discovery of Anticonvulsant Agents.
    Palestro PH; Enrique N; Goicoechea S; Villalba ML; Sabatier LL; Martin P; Milesi V; Bruno Blanch LE; Gavernet L
    J Chem Inf Model; 2018 Jul; 58(7):1331-1342. PubMed ID: 29870230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Machine Learning-Based Prediction Platform for P-Glycoprotein Modulators and Its Validation by Molecular Docking.
    Kadioglu O; Efferth T
    Cells; 2019 Oct; 8(10):. PubMed ID: 31640190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glabridin resensitizes p-glycoprotein-overexpressing multidrug-resistant cancer cells to conventional chemotherapeutic agents.
    Qian J; Xia M; Liu W; Li L; Yang J; Mei Y; Meng Q; Xie Y
    Eur J Pharmacol; 2019 Jun; 852():231-243. PubMed ID: 30959046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple transport-active binding sites are available for a single substrate on human P-glycoprotein (ABCB1).
    Chufan EE; Kapoor K; Sim HM; Singh S; Talele TT; Durell SR; Ambudkar SV
    PLoS One; 2013; 8(12):e82463. PubMed ID: 24349290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro and in silico evaluation of P-glycoprotein inhibition through
    Hosseini Balef SS; Piramoon M; Hosseinimehr SJ; Irannejad H
    Chem Biol Drug Des; 2019 Mar; 93(3):283-289. PubMed ID: 30270513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of anti-HIV protease inhibitors with the multidrug transporter P-glycoprotein (P-gp) in human cultured cells.
    Washington CB; Duran GE; Man MC; Sikic BI; Blaschke TF
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Nov; 19(3):203-9. PubMed ID: 9803961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Catalytic transitions in the human MDR1 P-glycoprotein drug binding sites.
    Wise JG
    Biochemistry; 2012 Jun; 51(25):5125-41. PubMed ID: 22647192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
    Lee TD; Lee OW; Brimacombe KR; Chen L; Guha R; Lusvarghi S; Tebase BG; Klumpp-Thomas C; Robey RW; Ambudkar SV; Shen M; Gottesman MM; Hall MD
    Mol Pharmacol; 2019 Nov; 96(5):629-640. PubMed ID: 31515284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In silico screening for inhibitors of p-glycoprotein that target the nucleotide binding domains.
    Brewer FK; Follit CA; Vogel PD; Wise JG
    Mol Pharmacol; 2014 Dec; 86(6):716-26. PubMed ID: 25270578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The reliability of molecular dynamics simulations of the multidrug transporter P-glycoprotein in a membrane environment.
    Condic-Jurkic K; Subramanian N; Mark AE; O'Mara ML
    PLoS One; 2018; 13(1):e0191882. PubMed ID: 29370310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Computational models for identifying potential P-glycoprotein substrates and inhibitors.
    Crivori P; Reinach B; Pezzetta D; Poggesi I
    Mol Pharm; 2006; 3(1):33-44. PubMed ID: 16686367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A plausible explanation for enhanced bioavailability of P-gp substrates in presence of piperine: simulation for next generation of P-gp inhibitors.
    Singh DV; Godbole MM; Misra K
    J Mol Model; 2013 Jan; 19(1):227-38. PubMed ID: 22864626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coarse-grained molecular dynamics simulations reveal lipid access pathways in P-glycoprotein.
    Barreto-Ojeda E; Corradi V; Gu RX; Tieleman DP
    J Gen Physiol; 2018 Mar; 150(3):417-429. PubMed ID: 29437858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.